The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
autophagy is a really difficult clinical investigation paradigm and i know you recently saw mitch weiss's paper on unpaired hemoglobins in thalassemia patients i was super excited when i read that paper because here is now a clinical paradigm where we can test drugs that augment autophagy and see something easily measurable in a not that rare patient population
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
here is now a clinical paradigm where we can test drugs that augment autophagy and see something easily measurable in a not that rare patient population